Research and Development

Gilead Sciences’ four-in-one HIV pill has been given the thumbs up by an FDA advisory group.  The US regulator is …

An FDA panel has recommended Arena’s obesity drug lorcaserin, setting up a showdown with Vivus’ Qnexa. Qnexa was recommended by an FDA panel …

Gamification is the new buzzword in digital marketing and has the potential to engage consumers more than traditional strategies. This new …

The senior vice president of discovery at UCB, Neil Weir, has been appointed as the next Chair of the ABPI …

Ex-BMS head Dr Jeremy Levin has been appointed president and chief executive of Teva.  Prior to joining Teva, Levin, who …

Robert Clark will be joining Novo Nordisk as vice president, regulatory affairs. Clark will lead Novo Nordisk’s US regulatory team, …

Teva has appointed Dr Michael Hayden as its new president of global R&D and chief scientific officer at the firm’s …

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …

Celgene has appointed Thomas Moriarty as its new general counsel and corporate secretary. In this position, he will be responsible …

Pfizer has released positive data for its established antidepressant Pristiq, as it hopes to extend the use of the drug.  …

We are all different. Different heights, shapes, hair colour and we are not just different physically – what about our …

James Shannon has been named GSK’s chief medical officer, and will report to R&D chairman Moncef Slaoui.  He will be …

Roche has abandoned its Phase III cholesterol treatment dalcetrapib after disappointing results.The manufacturer is ceasing work on the drug, once …

GlaxoSmithKline has forged another link with academia, signing a deal with Yale University to design a potential new class of …

GlaxoSmithKline has announced that Lynn Elsenhans and Jing Ulrich will join the Board of the Company with effect from 1 …